ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
TARIS Announces Positive Topline Data for TAR-302
americanpharmaceuticalreview
August 29, 2018TARIS announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of patients with idiopathic overactive bladder (OAB) refractory to oral therapy.
Pharma Sources Insight January 2025
